受强制性开放获取政策约束的文章 - David DeRemer了解详情
无法在其他位置公开访问的文章：2 篇
Investigational drugs targeting FLT3 for leukemia
C Ustun, DL DeRemer, AP Jillella, KN Bhalla
Expert Opinion on Investigational Drugs 18 (10), 1445-1456, 2009
强制性开放获取政策： US National Institutes of Health
Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter?
AB Clemmons, S Evans, DL DeRemer, FT Awan
Journal of Oncology Pharmacy Practice 21 (6), 425-432, 2015
强制性开放获取政策： Lymphoma Research Foundation, USA
可在其他位置公开访问的文章：16 篇
Antiangiogenic therapy for cancer: an update
B Al‐Husein, M Abdalla, M Trepte, DL DeRemer, PR Somanath
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (12 …, 2012
强制性开放获取政策： US National Institutes of Health
Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo
A Goc, B Al-Husein, K Katsanevas, A Steinbach, U Lou, H Sabbineni, ...
Oncotarget 5 (3), 775, 2014
强制性开放获取政策： US National Institutes of Health
Randomized, placebo-controlled, phase III trial of fosaprepitant, ondansetron, dexamethasone (FOND) versus FOND plus olanzapine (FOND-O) for the prevention of chemotherapy …
AB Clemmons, J Orr, B Andrick, A Gandhi, C Sportes, D DeRemer
Biology of Blood and Marrow Transplantation 24 (10), 2065-2071, 2018
强制性开放获取政策： US National Institutes of Health
How to Transition from Single Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial
CDHRM Marrero RJ, Cicali EJ, Arwood MJ, Eddy E, DeRemer D, Ramnaraign BH ...
Clin Pharmacol Ther 108 (3), 557-565, 2020
强制性开放获取政策： US National Institutes of Health
Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center
N Waheed, MG Fradley, DL DeRemer, A Mahmoud, CP Shah, ...
Cardio-oncology 7, 1-7, 2021
强制性开放获取政策： US National Institutes of Health
Adverse cardiovascular events associated with cyclin‐dependent kinase 4/6 inhibitors in patients with metastatic breast cancer
MG Fradley, NHK Nguyen, D Madnick, Y Chen, A DeMichele, I Makhlin, ...
Journal of the American Heart Association 12 (12), e029361, 2023
强制性开放获取政策： US National Institutes of Health, American Heart Association
Lactate dehydrogenase B and pyruvate oxidation pathway associated with carfilzomib-related cardiotoxicity in multiple myeloma patients: Result of a multi-omics integrative analysis
M Tantawy, LM Chekka, Y Huang, TJ Garrett, S Singh, CP Shah, ...
Frontiers in Cardiovascular Medicine 8, 645122, 2021
强制性开放获取政策： US National Institutes of Health
Anticancer activity of novel unnatural synthetic isoprenoids
VR Adams, DL Deremer, B Stevich, CA Mattingly, B Gallt, T Subramanian, ...
Anticancer research 30 (7), 2505-2512, 2010
强制性开放获取政策： US National Institutes of Health
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
DL DeRemer, NK Nguyen, A Guha, FS Ahmad, RM Cooper‐DeHoff, ...
Journal of the American Heart Association 12 (10), e027981, 2023
强制性开放获取政策： US National Institutes of Health
A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist
MC Awunti, DL DeRemer, S Rogers, L Scarton, L Adkins, DJ WIlkie, ...
Journal of the American College of Clinical Pharmacy 5 (12), 1284-1296, 2022
强制性开放获取政策： US National Institutes of Health
Cardiometabolic consequences of targeted anticancer therapies
A Guha, Y Gong, D DeRemer, J Owusu-Guha, SF Dent, RK Cheng, ...
Journal of cardiovascular pharmacology 80 (4), 515-521, 2022
强制性开放获取政策： US National Institutes of Health, American Heart Association
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
G Telisnor, DL DeRemer, E Frimpong, E Agyare, J Allen, L Ricks-Santi, ...
Journal of the National Medical Association 115 (2), 164-174, 2023
强制性开放获取政策： US National Institutes of Health
Unraveling racial disparities in supportive care medication use among end-of-life pancreatic cancer patients: Focus on pain management and psychiatric therapies
JM Allen, MC Awunti, Y Guo, J Bian, SC Rogers, L Scarton, DL DeRemer, ...
Cancer Epidemiology, Biomarkers & Prevention 32 (12), 1675-1682, 2023
强制性开放获取政策： US National Institutes of Health, State of Califonia
Research summary of poster presentations at the 2023 Florida cardio-oncology symposium
KA Bruno, WG O'Dell, M Tantawy, CL Casson, MC Ferrall-Fairbanks, ...
American Heart Journal Plus: Cardiology Research and Practice 37, 100348, 2024
强制性开放获取政策： US Department of Defense, US National Institutes of Health, American Heart …
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma
R Singhal, SC Rogers, JH Lee, B Ramnaraign, I Sahin, JC Fabregas, ...
Future Oncology 19 (27), 1843-1853, 2023
强制性开放获取政策： US National Institutes of Health
Cardiotoxicity associated with immune checkpoint inhibitors: A retrospective analysis of patients at an academic tertiary care center
N Waheed, MG Fradley, D DeRemer, A Mahmoud, CP Shah, TY Langaee, ...
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定